Breast Cancer Trial, Recruiting NCT05833659 Sponsor: Beijing Friendship Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05833659
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have been diagnosed with early-stage invasive breast cancer (stage I or stage II) confirmed by a biopsy before surgery.
  • People for whom breast-conserving surgery is not possible due to medical reasons, or who have chosen to have a full breast removal (mastectomy).
  • People who want to have breast reconstruction surgery.
  • People aged between 18 and 70 years.
  • People whose cancer tumour measures 3 cm or less at its widest point.
  • People whose tumour has been confirmed by physical examination and breast MRI scan to not have grown into the skin, tissue just under the skin, or the chest wall.
  • People where the tumour is at least 2 cm away from the nipple, and where physical examination and MRI confirm that the nipple and surrounding area are not affected by the cancer.
  • People who have a general health and activity level that falls within a specific range on a standard medical scale (confirm with trial site).

Who may not be able to join:

  • People who have had serious heart or blood vessel problems — such as unstable chest pain, a heart attack, or a stroke — within the past 6 months.
  • People who have been diagnosed with another cancer in the past 5 years.
  • People who are taking medicines to suppress their immune system following an organ transplant.
  • People who are currently on ongoing, long-term steroid hormone treatment taken throughout the body (not just a cream or local treatment).
  • People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: guoxuan gao, MD, Department of General Surgery, Beijing Friendship Hospital, Capital Medical University

Phone: +861063138712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Friendship Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
1 March 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

breast satisfaction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov